Format

Send to

Choose Destination
Cell Death Dis. 2018 Jul 26;9(8):818. doi: 10.1038/s41419-018-0848-7.

Activation of the DNA damage response in vivo in synucleinopathy models of Parkinson's disease.

Author information

1
Department of Molecular Genetics, Rotterdam, The Netherlands.
2
Laboratory of Functional Neurochemistry, IRCCS Mondino Foundation, 27100, Pavia, Italy.
3
German Centre for Neurodegenerative Diseases (DZNE), 53175, Bonn, Germany.
4
Department of Neuroscience, Erasmus MC, 3015 GE, Rotterdam, The Netherlands.
5
Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
6
CECAD, University of Cologne, Cologne, Germany.
7
Department of Molecular Genetics, Rotterdam, The Netherlands. p.g.mastroberardino@erasmusmc.nl.

Abstract

The involvement of DNA damage and repair in aging processes is well established. Aging is an unequivocal risk factor for chronic neurodegenerative diseases, underscoring the relevance of investigations into the role that DNA alterations may have in the pathogenesis of these diseases. Consistently, even moderate impairment of DNA repair systems facilitates the onset of pathological features typical of PD that include derangement of the dopaminergic system, mitochondrial dysfunction, and alpha-synuclein stress. The latter establishes a connection between reduced DNA repair capacity and a cardinal feature of PD, alpha-synuclein pathology. It remains to be determined, however, whether alpha-synuclein stress activates in vivo the canonical signaling cascade associated with DNA damage, which is centered on the kinase ATM and substrates such as γH2Ax and 53BP1. Addressing these issues would shed light on age-related mechanisms impinging upon PD pathogenesis and neurodegeneration in particular. We analyzed two different synucleinopathy PD mouse models based either on intranigral delivery of AAV-expressing human alpha-synuclein, or intrastriatal injection of human alpha-synuclein pre-formed fibrils. In both cases, we detected a significant increase in γH2AX and 53BP1 foci, and in phospho-ATM immunoreactivity in dopaminergic neurons, which collectively indicate DNA damage and activation of the DNA damage response. Mechanistic experiments in cell cultures indicate that activation of the DNA damage response is caused, at least in part, by pro-oxidant species because it is prevented by exogenous or endogenous antioxidants, which also rescue mitochondrial anomalies caused by proteotoxic alpha-synuclein. These in vivo and in vitro findings reveal that the cellular stress mediated by alpha-synuclein-a pathological hallmark in PD-elicits DNA damage and activates the DNA damage response. The toxic cascade leading to DNA damage involves oxidant stress and mitochondrial dysfunction The data underscore the importance of DNA quality control for preservation of neuronal integrity and protection against neurodegenerative processes.

Supplemental Content

Full text links

Icon for Nature Publishing Group Icon for PubMed Central
Loading ...
Support Center